Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,548,904Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Lexiscan

PharmaCompass

01

Brand Name : Lexiscan

Regadenoson

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lexiscan

arrow
2024 ACI Convention
Not Confirmed

Regadenoson

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 769

2020 Revenue in Millions : 542

Growth (%) : 100

blank

02

Brand Name : Lexiscan

Regadenoson

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lexiscan

arrow
2024 ACI Convention
Not Confirmed

Regadenoson

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 719

2021 Revenue in Millions : 768

Growth (%) : -6

blank